<?xml version="1.0" encoding="UTF-8"?>
<ANNEX xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:fmx="http://opoce" xsi:noNamespaceSchemaLocation="http://formex.publications.europa.eu/schema/formex-05.55-20141201.xd"><BIB.INSTANCE><DOCUMENT.REF FILE="L_2016039EN.01000501.doc.xml"><COLL>L</COLL><NO.OJ>039</NO.OJ><YEAR>2016</YEAR><LG.OJ>EN</LG.OJ><PAGE.FIRST>5</PAGE.FIRST><PAGE.SEQ>1</PAGE.SEQ><VOLUME.REF>01</VOLUME.REF></DOCUMENT.REF><DATE ISO="20160215">20160215</DATE><LG.DOC>EN</LG.DOC><NO.SEQ>0004.0001</NO.SEQ><PAGE.FIRST>9</PAGE.FIRST><PAGE.SEQ>1</PAGE.SEQ><PAGE.LAST>12</PAGE.LAST><PAGE.TOTAL>4</PAGE.TOTAL></BIB.INSTANCE><TITLE><TI><P>ANNEX I</P></TI></TITLE><CONTENTS><GR.SEQ LEVEL="1"><TITLE><TI><P><HT TYPE="BOLD">CRR Leverage Ratio — Disclosure Template</HT></P></TI></TITLE><TBL COLS="2" NO.SEQ="0001"><CORPUS><ROW><CELL COL="1">Reference date</CELL><CELL COL="2"><IE/></CELL></ROW><ROW><CELL COL="1">Entity name</CELL><CELL COL="2"><IE/></CELL></ROW><ROW><CELL COL="1">Level of application</CELL><CELL COL="2"><IE/></CELL></ROW></CORPUS></TBL><TBL COLS="3" NO.SEQ="0002"><TITLE><TI><P><HT TYPE="BOLD">Table LRSum: Summary reconciliation of accounting assets and leverage ratio exposures</HT></P></TI></TITLE><CORPUS><ROW TYPE="HEADER"><CELL COL="1" TYPE="HEADER"><IE/></CELL><CELL COL="2" TYPE="HEADER"><IE/></CELL><CELL COL="3" TYPE="HEADER"><HT TYPE="BOLD">Applicable Amount</HT></CELL></ROW><ROW><CELL COL="1">1</CELL><CELL COL="2">Total assets as per published financial statements</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">2</CELL><CELL COL="2">Adjustment for entities which are consolidated for accounting purposes but are outside the scope of regulatory consolidation</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">3</CELL><CELL COL="2">(Adjustment for fiduciary assets recognised on the balance sheet pursuant to the applicable accounting framework but excluded from the leverage ratio total exposure measure in accordance with Article 429(13) of Regulation (EU) No 575/2013)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">4</CELL><CELL COL="2">Adjustments for derivative financial instruments</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">5</CELL><CELL COL="2">Adjustment for securities financing transactions (SFTs)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">6</CELL><CELL COL="2">Adjustment for off-balance sheet items (ie conversion to credit equivalent amounts of off-balance sheet exposures)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-6a</CELL><CELL COL="2">(Adjustment for intragroup exposures excluded from the leverage ratio total exposure measure in accordance with Article 429(7) of Regulation (EU) No 575/2013)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-6b</CELL><CELL COL="2">(Adjustment for exposures excluded from the leverage ratio total exposure measure in accordance with Article 429(14) of Regulation (EU) No 575/2013)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">7</CELL><CELL COL="2">Other adjustments</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">8</CELL><CELL COL="2"><HT TYPE="BOLD">Leverage ratio total exposure measure</HT></CELL><CELL COL="3"><IE/></CELL></ROW></CORPUS></TBL><TBL COLS="3" NO.SEQ="0003"><TITLE><TI><P><HT TYPE="BOLD">Table LRCom: Leverage ratio common disclosure</HT></P></TI></TITLE><CORPUS><ROW TYPE="HEADER"><CELL COL="1" TYPE="HEADER"><IE/></CELL><CELL COL="2" TYPE="HEADER"><IE/></CELL><CELL COL="3" TYPE="HEADER"><HT TYPE="BOLD">CRR leverage ratio exposures</HT></CELL></ROW><BLK><TI.BLK COL.END="3" COL.START="1"><HT TYPE="BOLD">On-balance sheet exposures (excluding derivatives and SFTs)</HT></TI.BLK><ROW><CELL COL="1">1</CELL><CELL COL="2">On-balance sheet items (excluding derivatives, SFTs and fiduciary assets, but including collateral)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">2</CELL><CELL COL="2">(Asset amounts deducted in determining Tier 1 capital)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">3</CELL><CELL COL="2"><HT TYPE="BOLD">Total on-balance sheet exposures (excluding derivatives, SFTs and fiduciary assets) (sum of lines 1 and 2)</HT></CELL><CELL COL="3"><IE/></CELL></ROW></BLK><?PAGE NO="10"?><BLK><TI.BLK COL.END="3" COL.START="1"><HT TYPE="BOLD">Derivative exposures</HT></TI.BLK><ROW><CELL COL="1">4</CELL><CELL COL="2">Replacement cost associated with <HT TYPE="ITALIC">all</HT> derivatives transactions (ie net of eligible cash variation margin)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">5</CELL><CELL COL="2">Add-on amounts for PFE associated with <HT TYPE="ITALIC">all</HT> derivatives transactions (mark-to-market method)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-5a</CELL><CELL COL="2">Exposure determined under Original Exposure Method</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">6</CELL><CELL COL="2">Gross-up for derivatives collateral provided where deducted from the balance sheet assets pursuant to the applicable accounting framework</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">7</CELL><CELL COL="2">(Deductions of receivables assets for cash variation margin provided in derivatives transactions)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">8</CELL><CELL COL="2">(Exempted CCP leg of client-cleared trade exposures)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">9</CELL><CELL COL="2">Adjusted effective notional amount of written credit derivatives</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">10</CELL><CELL COL="2">(Adjusted effective notional offsets and add-on deductions for written credit derivatives)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">11</CELL><CELL COL="2"><HT TYPE="BOLD">Total derivatives exposures (sum of lines 4 to 10)</HT></CELL><CELL COL="3"><IE/></CELL></ROW></BLK><BLK><TI.BLK COL.END="3" COL.START="1"><HT TYPE="BOLD">SFT exposures</HT></TI.BLK><ROW><CELL COL="1">12</CELL><CELL COL="2">Gross SFT assets (with no recognition of netting), after adjusting for sales accounting transactions</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">13</CELL><CELL COL="2">(Netted amounts of cash payables and cash receivables of gross SFT assets)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">14</CELL><CELL COL="2">Counterparty credit risk exposure for SFT assets</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-14a</CELL><CELL COL="2">Derogation for SFTs: Counterparty credit risk exposure in accordance with Articles 429b(4) and 222 of Regulation (EU) No 575/2013</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">15</CELL><CELL COL="2">Agent transaction exposures</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-15a</CELL><CELL COL="2">(Exempted CCP leg of client-cleared SFT exposure)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">16</CELL><CELL COL="2"><HT TYPE="BOLD">Total securities financing transaction exposures (sum of lines 12 to 15a)</HT></CELL><CELL COL="3"><IE/></CELL></ROW></BLK><BLK><TI.BLK COL.END="3" COL.START="1"><HT TYPE="BOLD">Other off-balance sheet exposures</HT></TI.BLK><ROW><CELL COL="1">17</CELL><CELL COL="2">Off-balance sheet exposures at gross notional amount</CELL><CELL COL="3"><IE/></CELL></ROW><?PAGE NO="11"?><ROW><CELL COL="1">18</CELL><CELL COL="2">(Adjustments for conversion to credit equivalent amounts)</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">19</CELL><CELL COL="2"><HT TYPE="BOLD">Other off-balance sheet exposures (sum of lines 17 and 18)</HT></CELL><CELL COL="3"><IE/></CELL></ROW></BLK><BLK><TI.BLK COL.END="3" COL.START="1"><HT TYPE="BOLD">Exempted exposures in accordance with Article 429(7) and (14) of Regulation (EU) No 575/2013 (on and off balance sheet)</HT></TI.BLK><ROW><CELL COL="1">EU-19a</CELL><CELL COL="2">(Intragroup exposures (solo basis) exempted in accordance with Article 429(7) of Regulation (EU) No 575/2013 (on and off balance sheet))</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-19b</CELL><CELL COL="2">(Exposures exempted in accordance with Article 429 (14) of Regulation (EU) No 575/2013 (on and off balance sheet))</CELL><CELL COL="3"><IE/></CELL></ROW></BLK><BLK><TI.BLK COL.END="3" COL.START="1"><HT TYPE="BOLD">Capital and total exposure mesure</HT></TI.BLK><ROW><CELL COL="1">20</CELL><CELL COL="2"><HT TYPE="BOLD">Tier 1 capital</HT></CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">21</CELL><CELL COL="2"><HT TYPE="BOLD">Leverage ratio total exposure measure (sum of lines 3, 11, 16, 19, EU-19a and EU-19b)</HT></CELL><CELL COL="3"><IE/></CELL></ROW></BLK><BLK><TI.BLK COL.END="3" COL.START="1"><HT TYPE="BOLD">Leverage ratio</HT></TI.BLK><ROW><CELL COL="1">22</CELL><CELL COL="2"><HT TYPE="BOLD">Leverage ratio</HT></CELL><CELL COL="3"><IE/></CELL></ROW></BLK><BLK><TI.BLK COL.END="3" COL.START="1"><HT TYPE="BOLD">Choice on transitional arrangements and amount of derecognised fiduciary items</HT></TI.BLK><ROW><CELL COL="1">EU-23</CELL><CELL COL="2">Choice on transitional arrangements for the definition of the capital measure</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-24</CELL><CELL COL="2">Amount of derecognised fiduciary items in accordance with Article 429(11) of Regulation (EU) No 575/2013</CELL><CELL COL="3"><IE/></CELL></ROW></BLK></CORPUS></TBL><TBL COLS="3" NO.SEQ="0004"><TITLE><TI><P><HT TYPE="BOLD">Table LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures)</HT></P></TI></TITLE><CORPUS><ROW TYPE="HEADER"><CELL COL="1" TYPE="HEADER"><IE/></CELL><CELL COL="2" TYPE="HEADER"><IE/></CELL><CELL COL="3" TYPE="HEADER"><HT TYPE="BOLD">CRR leverage ratio exposures</HT></CELL></ROW><BLK><ROW><CELL COL="1">EU-1</CELL><CELL COL="2">Total on-balance sheet exposures (excluding derivatives, SFTs, and exempted exposures), of which:</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-2</CELL><CELL COL="2">Trading book exposures</CELL><CELL COL="3"><IE/></CELL></ROW><BLK><ROW><CELL COL="1">EU-3</CELL><CELL COL="2">Banking book exposures, of which:</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-4</CELL><CELL COL="2">Covered bonds</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-5</CELL><CELL COL="2">Exposures treated as sovereigns</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-6</CELL><CELL COL="2">Exposures to regional governments, MDB, international organisations and PSE <HT TYPE="UNDERLINE"><HT TYPE="BOLD">not</HT></HT> treated as sovereigns</CELL><CELL COL="3"><IE/></CELL></ROW><?PAGE NO="12"?><ROW><CELL COL="1">EU-7</CELL><CELL COL="2">Institutions</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-8</CELL><CELL COL="2">Secured by mortgages of immovable properties</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-9</CELL><CELL COL="2">Retail exposures</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-10</CELL><CELL COL="2">Corporate</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-11</CELL><CELL COL="2">Exposures in default</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">EU-12</CELL><CELL COL="2">Other exposures (eg equity, securitisations, and other non-credit obligation assets)</CELL><CELL COL="3"><IE/></CELL></ROW></BLK></BLK></CORPUS></TBL></GR.SEQ><GR.SEQ LEVEL="1"><TITLE><TI><P><HT TYPE="BOLD">CRR Leverage Ratio — Disclosure Template</HT></P></TI></TITLE><TBL COLS="3" NO.SEQ="0005"><TITLE><TI><P><HT TYPE="BOLD">Table LRQua: Free format text boxes for disclosure on qualitative items</HT></P></TI></TITLE><CORPUS><ROW TYPE="HEADER"><CELL COL="1" COLSPAN="2" TYPE="HEADER"><IE/></CELL><CELL COL="3" TYPE="HEADER"><HT TYPE="BOLD">Column</HT></CELL></ROW><ROW TYPE="HEADER"><CELL COL="1" COLSPAN="2" TYPE="HEADER"><IE/></CELL><CELL COL="3" TYPE="HEADER">Free format</CELL></ROW><ROW TYPE="HEADER"><CELL COL="1" TYPE="HEADER"><HT TYPE="BOLD">Row</HT></CELL><CELL COL="2" COLSPAN="2" TYPE="HEADER"><IE/></CELL></ROW><ROW><CELL COL="1">1</CELL><CELL COL="2">Description of the processes used to manage the risk of excessive leverage</CELL><CELL COL="3"><IE/></CELL></ROW><ROW><CELL COL="1">2</CELL><CELL COL="2">Description of the factors that had an impact on the leverage Ratio during the period to which the disclosed leverage Ratio refers</CELL><CELL COL="3"><IE/></CELL></ROW></CORPUS></TBL></GR.SEQ></CONTENTS></ANNEX>